Welcome to LookChem.com Sign In|Join Free
  • or
7-Iodo[1,2,4]triazolo[1,5-a]pyridine is a chemical compound with the molecular formula C6H4IN5. It is a derivative of triazolopyridine, characterized by a triazole ring fused with a pyridine ring and an iodine atom attached to one of the carbon atoms. 7-IODO[1,2,4]TRIAZOLO[1,5-A]PYRIDINE is commonly used in medicinal and pharmaceutical research due to its potent inhibitory effects on certain enzymes and its potential in treating various diseases, including cancer and neurological disorders. Its unique structure and biological activities make it an important molecule in drug discovery and development.

690258-25-4

Post Buying Request

690258-25-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

690258-25-4 Usage

Uses

Used in Pharmaceutical Research:
7-Iodo[1,2,4]triazolo[1,5-a]pyridine is used as a research compound for its potent inhibitory effects on certain enzymes. Its unique structure allows it to target specific biological pathways, making it a valuable tool in the development of new drugs.
Used in Cancer Treatment:
In the field of oncology, 7-Iodo[1,2,4]triazolo[1,5-a]pyridine is used as a potential therapeutic agent for the treatment of various types of cancer. Its ability to inhibit specific enzymes involved in cancer cell growth and proliferation makes it a promising candidate for further research and development.
Used in Neurological Disorders Treatment:
7-Iodo[1,2,4]triazolo[1,5-a]pyridine is also used in the research and development of treatments for neurological disorders. Its potential to modulate specific enzymes and biological pathways involved in these conditions makes it a valuable compound for exploring new therapeutic approaches.
Used in Drug Discovery:
Due to its unique structure and biological activities, 7-Iodo[1,2,4]triazolo[1,5-a]pyridine is used as a key molecule in drug discovery. Its ability to target specific enzymes and pathways makes it a promising starting point for the development of new drugs with improved efficacy and selectivity.

Check Digit Verification of cas no

The CAS Registry Mumber 690258-25-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,0,2,5 and 8 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 690258-25:
(8*6)+(7*9)+(6*0)+(5*2)+(4*5)+(3*8)+(2*2)+(1*5)=174
174 % 10 = 4
So 690258-25-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H4IN3/c7-5-1-2-10-6(3-5)8-4-9-10/h1-4H

690258-25-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Iodo-[1,2,4]triazolo[1,5-a]pyridine

1.2 Other means of identification

Product number -
Other names 7-iodo-[1,2,4]triazolo[1,5-a]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:690258-25-4 SDS

690258-25-4Downstream Products

690258-25-4Relevant academic research and scientific papers

BENZYL-, (PYRIDIN-3-YL)METHYL- OR (PYRIDIN-4-YL)METHYL-SUBSTITUTED OXADIAZOLOPYRIDINE DERIVATIVES AS GHRELIN O-ACYL TRANSFERASE (GOAT) INHIBITORS

-

Page/Page column 79; 81; 93, (2019/08/26)

The present invention relates to compounds of general formula (I), wherein the groups R1 and R2 are defined as in claim 1, which have valuable pharmacological properties, in particular bind to ghrelin O-acyl transferase (GOAT) and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular obesity.

(2S,3S)-3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1, 2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: A selective α-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

Edmondson, Scott D.,Mastracchio, Anthony,Mathvink, Robert J.,He, Jiafang,Harper, Bart,Park, You-Jung,Beconi, Maria,Di Salvo, Jerry,Eiermann, George J.,He, Huaibing,Leiting, Barbara,Leone, Joseph F.,Levorse, Dorothy A.,Lyons, Kathryn,Patel, Reshma A.,Patel, Sangita B.,Petrov, Aleksandr,Scapin, Giovanna,Shang, Jackie,Roy, Ranabir Sinha,Smith, Aaron,Wu, Joseph K.,Xu, Shiyao,Zhu, Bing,Thornberry, Nancy A.,Weber, Ann E.

, p. 3614 - 3627 (2007/10/03)

A series of β-substituted biarylphenylalanine amides were synthesized and evaluated as inhibitors of dipeptidyl peptidase IV (DPP-4) for the treatment of type 2 diabetes. Optimization of the metabolic profile of early analogues led to the discovery of (2S

PHENYLALANINE DERIVATIVES AS DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES

-

Page 85, (2010/02/07)

The present invention is directed to phenylalanine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 690258-25-4